SOURCE: U.S. BioDefense, Inc.

August 28, 2007 09:30 ET

U.S. BioDefense Announces Share Distribution for Subsidiary Spin Out

CITY OF INDUSTRY, CA--(Marketwire - August 28, 2007) - U.S. BioDefense, Inc. (OTCBB: UBDE) today announces that is has filed an information statement on Schedule 14C to formally announce that all shareholders of record as of date of September 7, 2007 will receive a dividend share distribution of Emergency Disaster Systems, Inc. U.S. BioDefense shareholders will receive 1 share of EDS for every 100 shares of U.S. BioDefense. The actions were approved by the Board of Directors and are expected to be ratified by the majority shareholder on or before September 27, 2007.

On July 31, 2007 the company announced that it planned to file Form SB-2 Registration Statement with the Securities and Exchange Commission to distribute shares of common stock of Emergency Disaster Systems and it would apply to be listed on the OTCBB.

About U.S. BioDefense, Inc.

U.S. BioDefense, Inc. is a Department of Defense Central Contractor that researches, develops, and commercializes homeland security and leading-edge biotechnologies. U.S. BioDefense is focused on transferring, researching, and commercializing groundbreaking technologies from Universities, Research Labs, Fortune 500 Companies, and Government Agencies. Through its subsidiary, Emergency Disaster Systems, Inc. (EDS), the company operates its Emergency Preparedness Program as part of its Homeland Security division. U.S. BioDefense is focused on developing EDS as an industry leader in the disaster mitigation and preparedness arena, an underserved market that could see consumer spending of over 24 billion dollars in 2007.

About Emergency Disaster Systems, Inc.

Emergency Disaster Systems, Inc. (EDS) is a subsidiary of U.S. BioDefense, Inc. and a leading provider of disaster mitigation services, emergency preparedness, and first response products to local communities, government agencies and Fortune 500 companies. EDS is committed to the protection of children's lives and communities from the devastating aftermath of a catastrophic event.

Forward-Looking Statement

This press release includes certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on the current expectations or beliefs of management of U.S. BioDefense, Inc., and are subject to uncertainty and changes in circumstances. Actual results may vary materially from those expressed or implied by the statements herein due to changes in economic, business, competitive, technological and/or regulatory factors, and other factors affecting the operation of the businesses of U.S. BioDefense, Inc. U.S. BioDefense, Inc. is under no obligation to, and expressly disclaims any such obligation to, update or alter the respective forward-looking statements, whether as a result of new information, future events, or otherwise.

For more information about Emergency Disaster Systems, please visit

Contact Information

  • Contact:
    David Chin
    U.S. BioDefense, Inc.
    Tel: (626) 961-0562